Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending May 2014. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting held on May 7, 2014.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure and share buyback activity.
- Shares Purchased: 529,000 Ordinary Shares on May 19, 2014.
- Price Range: Highest price paid was 1,628.00 pence; lowest price paid was 1,616.00 pence.
- Treasury Holdings (Settled): 491,133,712 shares (9.18% of total issued share capital).
- Treasury Holdings (Including Unsettled): 492,395,812 shares (10.13% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,859,366,116 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 529,000 shares for Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 10.13% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance notification under the Financial Conduct Authority's Disclosure and Transparency Rules regarding the execution of a share buyback program.
Investor Verification Checklist
- Verify the total number of shares held in Treasury against the latest quarterly or annual reports to confirm the 9.18% to 10.13% range.
- Confirm the total issued share capital to validate the denominator used for voting rights calculations (4,859,366,116 shares).
- Check subsequent filings to determine if the 529,000 shares purchased on May 19, 2014, were fully settled and retired or retained in Treasury.
- Review the authorization limits from the May 7, 2014, Annual General Meeting to assess remaining capacity for future buybacks.